I

International Devices & Diagnostics Monitor

About

Bio

FDAnews.com covers domestic and international regulatory, legislative and business news and information for executives in industries regulated by the U.S. Food and Drug Administration, including four newsletters: Drug GMP Report, Drug Industry Daily, International Devices & Diagnostics Monitor and The GMP Letter.

Email

email@cision.one

Website

site@cision.one

Social media

linkedin x facebook reddit

Location

United States of America

Frequency

upgrade

Circulation

upgrade

Sectors

Government Agencies, Medical Equipment, Medical Technology, Pharmaceutical Manufacturers


Is this you? We'd love to hear from you, contact our journalist team.
Contact us to unlock the full profile

Most recent articles by International Devices & Diagnostics Monitor

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet
Contact us to explore recent articles

Explore outlets similar to International Devices & Diagnostics Monitor

  • N
    National Review

    Designed as a journal of conservative opinion. Covers the national and international developments related to conservative action and reports and analyzes on what various conservatives are saying, thinking and doing. Committed to providing important, expert analyses of the day’s hottest stories and to breaking those stories in a manner consistent with the publication's worldview.

    View
  • I
    Industry Dive

    Industry Dive is a Business news publication that takes a deep dive into 16 of the most competitive industries. Industries included on website: BioPharma, CIO, Construction, Education, Food, Grocery, HR, Healthcare, Marketing, MedTech, Restaurant, Retail, Smart Cities, Supply Chain, Utility, and Waste.

    View
  • T
    Thomson Reuters Foundation

    Background and Format The Thomson Reuters Foundation, the charitable arm of Thomson Reuters, covers the world’s under-reported stories, with a global team of about 40 staff journalists on humanitarian crises, women’s empowerment, the human impact of climate change, property rights, and trafficking and slavery. All of its stories are published on its news website, news.trust.org, as well as distributed on the Reuters news wire.   Established in 1983 as a training programme for journalists in developing countries, the Thomson Reuters Foundation promotes free, independent journalism through its continued training programmes and also acts to promote socio-economic progress worldwide. As well as its news service and journalism training, the Foundation runs Trust Law - which connects law firms providing pro bono work to NGOs and social enterprises -  and holds the annual Trust Women conference focused on empowering women and combating trafficking and slavery. Trust.org is the Foundation’s main website. Audience and Readership: People interested in humanitarian stories as well as campaigners and lawyers along with people working in law enforcement, politics and global business. Deadline: Best to contact in the morning. Frequency: Daily - online. Monthly Unique Users: This figure is not available. Distribution: Content is produced for the website and also distributed through the Reuters news wire. Awards: 2013 - Online Media Awards, Best National/World News Site: for Aswat Masriya (nominated) Other Information: The Foundation hold an annual conference called Trust Women which brings together campaigners, filmmakers, lawyers, senior figures from law enforcement, politics, the judiciary and global business to take action to advance the status of women and their rights. PRs can get involved by sending us ideas for speakers - individuals who are leaders in their field – to media.foundation@thomsonreuters.com. It also provides the TrustLaw global pro bono legal programme connecting NGOs and social entrepreneurs with big law firms. They like to receive new ideas from PRs and quirky stories. Embargoed content is preferable - or to at least receive a story well ahead of time. They're particularly interested in 'people stories', a story that has a human face. Whatever they receive, it must fit into their remit, content has to have a global view and focus on under reported stories, humanitarian relief, governance, trafficking and slavery, and must promote socio-economic progress. The team are also available to moderate at presentations and conferences if it can promote the Foundation.

    View
  • M
    Modern Healthcare

    Established in 1974 and written for hospital and health system executives as an industry-intensive news source. Editorial concentrates on issues, news and trends affecting healthcare in the United States and provides information to healthcare professionals on topics including finance, integrated delivery systems, technology, politics, labor, managed care, physician issues, developments in federal and state government, court rulings, policy and regulation and marketing. There is a particular emphasis on coverage of electronic medical records. Regular features provide up to the minute news and trends in the healthcare field and discusses physician issues, innovative strategies and studies, future developments within this field and personnel updates. Departments include: The Week in Healthcare, Late News, Opinions/Editorials, Cover Story and Features. Topics regularly covered include: human resources, finance, legal affairs, managed care, policy and technology. Special sections included are: Profile, an in-depth look at a healthcare industry leader; Medical Advances, how the latest developments in medicine, biotechnology, pharmaceuticals and medical technology will affect your business; By the Numbers, a look at healthcare statistics and figures; and The Edge, how information technology is helping healthcare management solve clinical, financial and strategic challenges. Modern Healthcare does not publish unsolicited news articles or "byline" articles from outside firms. All of the editorial content is developed by staff or commissioned from freelance writers.

    View
  • P
    Pink Sheet

    Written for executives and administrators in the pharmaceutical and biotechnology industries. Highlights all aspects of the pharmaceutical industry, including marketing, research and development and regulatory and legislative issues. Regular features include regulatory news, drug approvals, FDA advisory committee meetings, enforcement reports, business and marketing news, financial news and managed care developments.

    View
Use CisionOne to find more relevant outlets

Explore journalists that write for International Devices & Diagnostics Monitor

Contact us to find more relevant journalists

Contact International Devices & Diagnostics Monitor and get access to over 850K accurate, up-to-date media profiles.

Discover the stories that impact your brand. In realtime.

CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.